These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8300449)

  • 1. Role of cell-binding in the antibacterial mechanism of lactoferricin B.
    Bellamy WR; Wakabayashi H; Takase M; Kawase K; Shimamura S; Tomita M
    J Appl Bacteriol; 1993 Nov; 75(5):478-84. PubMed ID: 8300449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.
    Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH
    FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
    Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
    Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
    Haug BE; Svendsen JS
    J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
    Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin.
    Bellamy W; Wakabayashi H; Takase M; Kawase K; Shimamura S; Tomita M
    Med Microbiol Immunol; 1993 May; 182(2):97-105. PubMed ID: 8332105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin.
    Nguyen LT; Schibli DJ; Vogel HJ
    J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lactoferricin B, a pepsin-generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pRI203) entry into HeLa cells.
    Longhi C; Conte MP; Bellamy W; Seganti L; Valenti P
    Med Microbiol Immunol; 1994 May; 183(2):77-85. PubMed ID: 7935162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
    Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
    Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
    Farnaud S; Patel A; Odell EW; Evans RW
    FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes.
    Ulvatne H; Haukland HH; Olsvik O; Vorland LH
    FEBS Lett; 2001 Mar; 492(1-2):62-5. PubMed ID: 11248238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B.
    Samuelsen O; Haukland HH; Kahl BC; von Eiff C; Proctor RA; Ulvatne H; Sandvik K; Vorland LH
    J Antimicrob Chemother; 2005 Dec; 56(6):1126-9. PubMed ID: 16287983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes.
    Aguilera O; Ostolaza H; Quirós LM; Fierro JF
    FEBS Lett; 1999 Dec; 462(3):273-7. PubMed ID: 10622710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment.
    Yamauchi K; Tomita M; Giehl TJ; Ellison RT
    Infect Immun; 1993 Feb; 61(2):719-28. PubMed ID: 8423097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
    Haug BE; Andersen J; Rekdal O; Svendsen JS
    J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives.
    de Armas RR; Díaz HG; Molina R; Uriarte E
    Biopolymers; 2005 Apr; 77(5):247-56. PubMed ID: 15682438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clofoctol binding by the bacteria (author's transl)].
    Combe J; Simonnet F; Yablonsky F; Simonnet G
    J Pharmacol; 1980; 11(4):411-25. PubMed ID: 6782374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line.
    Freiburghaus C; Janicke B; Lindmark-Månsson H; Oredsson SM; Paulsson MA
    J Dairy Sci; 2009 Jun; 92(6):2477-84. PubMed ID: 19447979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.